NKT-cell subsets: Promoters and protectors in inflammatory liver disease

被引：103
|
作者：
Kumar, Vipin [1 ]
机构：
[1] Torrey Pines Inst Mol Studies, Lab Autoimmun, San Diego, CA 92121 USA
来源：
JOURNAL OF HEPATOLOGY | 2013年 / 59卷 / 03期
关键词：
NK T cells; Sulfatide; Hepatitis; Inflammation;
D O I：
10.1016/j.jhep.2013.02.032
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：618 / 620
页数：3
相关论文
共 50 条
  • [31] A biased Vα24+ T-cell repertoire leads to circulating NKT-cell defects in a multiple sclerosis patient at the onset of his disease
    Démoulins, T
    Gachelin, G
    Bequet, D
    Dormont, D
    IMMUNOLOGY LETTERS, 2003, 90 (2-3) : 223 - 228
  • [32] Antigen electroporated DC loaded with NKT-cell ligand induces the antigen specific antitumor immunity.
    Watanabe, Akihiro
    Yamashita, Kimihiro
    Arimoto, Akira
    Yamada, Kouta
    Agawa, Kyosuke
    Kamigaki, Takashi
    Takimioto, Rishu
    Kakeji, Yoshihiro
    CANCER RESEARCH, 2021, 81 (13)
  • [33] Natural killer T (NKT) cell subsets in chlamydial infections
    Yang, Xi
    IMMUNE-MEDIATED DISEASES: FROM THEORY TO THERAPY, 2007, 601 : 243 - 246
  • [34] The effects of IL-2 and IL-15 on NKT-cell activation and cytotoxicity against leukaemic cell lines
    Rees, B. M.
    Allen, J. E.
    Morse, H. R.
    Donaldson, C.
    BRITISH JOURNAL OF HAEMATOLOGY, 2010, 149 : 69 - 69
  • [35] A novel mechanism involving NKT17 and NKT1/2 subsets in different phases of non-alcoholic fatty liver disease
    Marrero, Idania
    Maricic, Igor
    Eguchi, Akiko
    Dasgupta, Surya
    Feldstein, Ariel E.
    Hernandez, Carolyn
    Loomba, Rohit
    Kumar, Vipin
    Marrero, Idania
    Kumar, Vipin
    HEPATOLOGY, 2017, 66 : 87A - 88A
  • [36] α-Galactosylceramide Promotes Killing of Listeria monocytogenes within the Macrophage Phagosome through Invariant NKT-Cell Activation
    Emoto, Masashi
    Yoshida, Tomomi
    Fukuda, Toshio
    Kawamura, Ikuo
    Mitsuyama, Masao
    Kita, Eiji
    Hurwitz, Robert
    Kaufmann, Stefan H. E.
    Emoto, Yoshiko
    INFECTION AND IMMUNITY, 2010, 78 (06) : 2667 - 2676
  • [37] Differential antitumor immunity mediated by NKT cell subsets in vivo
    Crowe, NY
    Coquet, JM
    Berzins, SP
    Kyparissoudis, K
    Keating, R
    Pellicci, DG
    Hayakawa, Y
    Godfrey, DI
    Smyth, MJ
    JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 202 (09): : 1279 - 1288
  • [38] The adaptor protein SAP regulates type II NKT-cell development, cytokine production, and cytotoxicity against lymphoma
    Weng, Xiufang
    Liao, Chia-Min
    Bagchi, Sreya
    Cardell, Susanna L.
    Stein, Paul L.
    Wang, Chyung-Ru
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2014, 44 (12) : 3646 - 3657
  • [39] NKT cell regulation of inflammatory B cell responses
    Enoksson, S. L.
    Grasset, E.
    Hagglof, T.
    Mattsson, N.
    Gabrielsson, S.
    McGaha, T. L.
    Scheynius, A.
    Karlsson, M.
    IMMUNOLOGY, 2011, 135 : 14 - 14
  • [40] IL-21 maintains CD62L expression during NKT-cell ex vivo expansion and enhances antitumor activity of NKT cell therapy in vivo
    Ngai, Ho
    Tian, Gengwen
    Courtney, Amy N.
    Marinova, Ekaterina
    Huang, Wei
    Guo, Linjie
    Metelitsa, Leonid S.
    JOURNAL OF IMMUNOLOGY, 2017, 198 (01):
12345